Welcome to the House Committee on Energy and Commerce

WASHINGTON, D.C.  – Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, and Congressman Richard Hudson (NC-09), Chairman of the Subcommittee on Communications and Technology, recently  sent a letter  to Commerce Secretary Howard Lutnick asking the U.S. Department of Commerce to investigate the Spanish government’s decision to contract Huawei to manage and store sensitive data relating to the country’s wiretapping services. “I am deeply concerned by reports that Spain has contracted with Huawei to manage and store sensitive data related to the country’s wiretapping services. This decision is highly problematic, given Huawei’s well-documented ties to the Chinese Communist Party and the potential national security risks such involvement poses,” said Chairman Bilirakis. “Entrusting such critical infrastructure to an entity under significant influence from a foreign authoritarian government could jeopardize not only Spain’s internal security but also the integrity of allied intelligence sharing frameworks. This is a matter of national security, and we cannot afford to be complacent.” “Spain’s decision to hand Huawei access to sensitive law enforcement data is deeply troubling and a direct risk to our shared security,”   said Chairman Hudson. “Huawei’s ties to the Chinese Communist Party are well-documented, and this move undermines the trust and transparency that should define our alliances. The United States cannot accept double standards that block American digital trade while turning a blind eye to Chinese intrusion.” KEY EXCERPT: “It is deeply troubling when a treaty ally uses telecommunications equipment and services from an entity aligned with the Chinese Communist Party (CCP). As you are aware, Huawei and other Chinese firms maintain documented CCP ties, posing profound risks to national and economic security.”  […] “Spain’s decision underscores a regrettable trend in the European Union (EU): governments tacitly embrace Chinese technology and hold American digital trade exports to double standards.” BACKGROUND: In 2019, the Trump Administration prohibited Huawei from participating in U.S. telecommunications networks over their ties to the CCP. In 2020, President Trump signed the  Secure and Trusted Communications Networks Act  to prohibit federal funds from being used to purchase untrustworthy equipment and help small providers remove and replace such equipment. The People’s Republic of China (PRC) National Intelligence Law of 2017 requires PRC individuals and entities to support PRC intelligence services. The EU is the largest destination for American digital trade exports, and digital trade supports more than 3 million American jobs, which means Spain’s decision could directly impact U.S. businesses and individuals. CLICK HERE  to read  Fox Business  coverage of the letter. CLICK HERE  to read the full letter. ###

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement regarding the Department of Energy’s (DOE) announcement that it would issue funding opportunities to support the mining and processing of critical materials and minerals. “Ensuring that the United States has access to the critical materials and minerals that are used in everything from cell phones and missile guidance technology to energy applications must be one of our top priorities. Over the past several months, our Committee has held multiple hearings on the urgent need to secure our critical mineral and material supply chains, including by increasing domestic mining and finding new ways to recycle these materials from coal ash and electronic waste,”   said Chairman Guthrie .  “As we continue to counter adversaries, like China, the Department of Energy’s announcement is a strong step toward ensuring that Americans will continue to have access to the tools and technologies we rely on.” CLICK HERE  to read the DOE’s announcement. ###

WASHINGTON, D.C.  – Last month, the House Committee on Energy and Commerce’s Subcommittee on Oversight and Investigations held a hearing diving deeper into concerning practices within our nation’s organ procurement and transplant system that were identified by a recent Health Resources and Services Administration (HRSA) investigation. During the two-panel hearing titled “Ensuring Patient Safety: Oversight of the U.S. Organ Procurement and Transplant System,” Committee Members heard from the Chief of the Organ Transplant Branch of HRSA regarding the agency’s recently released investigative report outlining shocking revelations about the system’s procedures that put patient safety at risk. The investigation examined an “index case” (KYDA-001) where the organ procurement organization (OPO) that services Kentucky was contacted shortly after the arrival of a patient who was experiencing cardiovascular collapse after an unintentional overdose. After it was determined that further treatment would be futile, the patient’s family made the decision to end life-sustaining treatment and move forward with organ donation via a process known as donation after cardiac (or circulatory) death (DCD). However, despite OPO and hospital staff noting signs of the patient’s improved neurologic function, discomfort, and even expression of fear at multiple points over the multi-day period between when the OPO was first contacted and the patient was brought to the operating room (OR), the decision to pursue organ recovery was not reversed until the physician in the OR became uncomfortable and refused to continue with the process. In addition to the index case, HRSA analyzed 351 unique cases of authorized, not recovered (ANR) patients. This means that the patients were considered for DCD recovery, but no organs were transplanted. The report shows that 103 of these cases, which is nearly 30 percent, “had concerning features.”  HRSA’s Organ Transplant Branch Chief, Dr. Raymond Lynch, testified about KYDA’s (Network for Hope) patterns that were identified in the report, which include: A failure to recognize neurologic function inconsistent or unfavorable for DCD organ recovery on initial patient assessment or subsequent follow up; A failure to work collaboratively with patients’ primary medical teams, including instances of potential violation of separation of roles in patient care; A failure to respect family wishes and appropriately safeguard the decision-making authority of legal next of kin; and A failure to follow professional best practices as well as policies and guidelines for collection of patients’ medical data. The second panel included witnesses from “Network for Hope,” the OPO involved in all of the cases that HRSA reviewed; the United Network for Organ Sharing (UNOS); and the current and recent past President of the Organ Procurement and Transplantation Network (OPTN) Board of Directors.  Chairman Joyce probed Network for Hope CEO, Mr. Barry Massa, for using the word “unique” to describe the index case, the same case where “...hospital staff [felt] extremely uncomfortable with the amount of reflexes patient is exhibiting,” during the procurement process. Congressman Gary Palmer (AL-06) questioned witnesses about an open letter that was issued after the Subcommittee’s September 2024 hearing and signed by the organ donation and transplant industry and community members, including individuals at UNOS and OPTN Board Members. The open letter, per HRSA’s report, “characterized the ongoing effort to improve patient safety through enhanced oversight as a ‘misinformation campaign,’” noting that “[i]t is time for it to stop.” Specifically, the letter portrayed the previous oversight efforts by this Committee as “[s]preading misinformation based on conspiracy theories and hearsay.” UNOS’s CEO, Dr. Maureen McBride, admitted to signing the letter.  The Committee has serious concerns about the message this letter sends both to those conducting oversight of the organ procurement and transplant system and to those who wish to speak up when they wish to report concerns or potential wrongdoing. Oversight of this issue is far from over, and the Committee remains committed to protecting patient safety and maintaining trust in the system to ensure transparency and accountability. As Chairman Guthrie said when recalling his personal experience with our nation’s organ procurement and transplant system, “The conclusion [of this process] is going to come when we have confidence in the system.” ###

WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, along with Reps. Palmer (AL-06), Carter (GA-01), Bilirakis (FL-12), and Obernolte (CA-23), penned a letter to the Executive Director of Covered California (CoveredCA), Jessica Altman, to request further information related to the potentially unauthorized transmission of sensitive personal health information involving Covered California’s website. Key Letter Excerpt: “According to public reports and agency statements, tracking technology was embedded on Covered California's website beginning in February 2024, as part of a broader digital advertising effort, and in direct contravention of the tracking platform’s user agreement, which prohibits the use of such tools on pages that collect sensitive health information. Although the tags were reportedly removed in April 2025, following external scrutiny and a vendor transition, the extended period of data exposure raises serious questions about the adequacy of safeguards that Covered California had in place. Forensic testing by investigative reporters identified the trackers in operation and confirmed that user-entered health information was being transmitted to third parties without consent. These circumstances warrant examination of Covered California’s actions under federal privacy standards.” “Ensuring the confidentiality of health information is a foundational obligation for entities operating within the health insurance ecosystem. Federal privacy protections, particularly the Health Insurance Portability and Accountability Act (HIPAA), establish expectations for how covered organizations handle sensitive data. Recent reports and public filings raised questions about whether those expectations were met in this case, and whether existing oversight mechanisms are sufficient to detect and prevent improper disclosures.” Background: Forensic testing shows Covered California —the State of California’s official health insurance marketplace—has been sending sensitive user health data to third-party websites through several online data trackers. Prior to removal of the trackers, CoveredCA had more than 60 trackers active on its website; the average number of trackers on a government website is three. Some types of information sent to such websites include: Searches for doctors in network with specific plans/specializations Demographic information, including gender, ethnicity, and marital status Length of treatment a patent received by a provider Frequency of doctor visits If the user indicated they were blind, pregnant, a victim of domestic abuse, or used prescription medications. The State of California independently operates CoveredCA. As the state’s official ACA marketplace, CoveredCA falls under the purview of Health Insurance Portability and Accountability Act (HIPAA). The disclosure of information such as pregnancy or prescription drug use without proper consent—even for “marketing purposes”—may violate HIPAA. This Congress, the Committee has sent letters to 23andMe and DeepSeek over potential data privacy concerns: The Committee also held a hearing last Congress on the Change Healthcare hack, where personal health information was also jeopardized. CLICK HERE to read Fox News coverage of the letter. CLICK HERE to view the full letter. ###

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman Richard Hudson (NC-09), Chairman of the Subcommittee on Communications and Technology, sent a letter to President Donald J. Trump urging the administration to quickly remove burdensome regulations that have stopped the Broadband Equity, Access, and Deployment (BEAD) program from connecting any American to reliable broadband. KEY EXCERPT: “The Biden administration added unnecessary and burdensome requirements that made participation in the program more expensive and less attractive to broadband providers. These include labor and climate change requirements, as well as rate regulation of low-cost broadband plans that were unlawfully imposed.  “To address these issues, we introduced the Streamlining Program Efficiency and Expanding Deployment (SPEED) for BEAD Act, which outlines necessary reforms to BEAD. We appreciate that Secretary of Commerce Howard Lutnick is undertaking a review of the program and urge any reforms to be enacted as soon as possible.” BACKGROUND: On March 5, 2025,  Congressman Hudson introduced  the SPEED for BEAD Act to remove harmful regulations that have prevented the $42 billion program from laying even a single inch of fiber to support rural Americans. Also on March 5, 2025, the Committee on Energy and Commerce  held a hearing  to discuss the BEAD program titled  Fixing Biden’s Broadband Blunder. CLICK HERE to read the full letter. ###

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, Congressman Gus Bilirakis (FL-12), Chairman of the Subcommittee on Commerce, Manufacturing, and Trade, and Congressman Gary Palmer (AL-06), Chairman of the Subcommittee on Oversight and Investigations, sent a letter to 23andMe regarding the handling of Americans' sensitive data following the company's decision to file for bankruptcy. KEY EXCERPT: “According to 23andMe’s privacy statement, in a bankruptcy, customers’ ‘Personal Information may be accessed, sold or transferred as part of that transaction and this Privacy Statement will apply to [customer] Personal Information as transferred to the new entity.’ Additionally, a judge recently ruled 23andMe has the right to sell the sensitive medical and genetic information of its 15 million customers, which is considered to be the company’s most valuable asset. With the lack of a federal comprehensive data privacy and security law, we write to express our great concern about the safety of Americans’ most sensitive personal information.” Background: On March 23, 2025, 23andMe initiated Chapter 11 bankruptcy proceedings, which could have ramifications for the highly sensitive information of millions of Americans. While Americans’ personal health information is protected under the Health Insurance Portability and Accountability Act (HIPAA), these protections only apply if the information is collected by a HIPAA covered entity. Generally, direct-to-consumer companies, like 23andMe, are not covered by HIPAA. Customers have reported issues accessing and deleting their data from their 23andMe accounts. The Chairmen have requested answers to the following questions: If 23andMe were to sell the personal information of its customers either as a standalone asset or as part of a broader sale of the company, what post-sale data privacy and security protections would be in place for its customers’ personal information? Please describe how the representations made in 23andMe’s privacy statement will continue to apply—and be enforced—if the personal information of 23andMe’s customers is sold to a third party. Please include in this response information about what, if anything, would hold a third-party buyer to 23andMe’s privacy statement or prevent it from subsequently using, transferring, or otherwise selling, such information in the future. Does 23andMe plan to change its privacy statement at any time prior to selling any customers’ personal information? If so, please explain the change 23andMe plans to implement and when those changes will go into effect. Does 23andMe intend to vet prospective buyers to which it may sell its customers’ personal information? If so, please detail the vetting process and whether it will include the prospective buyer’s history of implementing data security protections and compliance with sectoral, state, or any other data privacy and security laws. If not, please explain why. Please detail the categories of customer information 23andMe has, and of that what 23andMe is considering selling. Has 23andMe notified its customers of the company’s bankruptcy announcement? If so, please attach the customer notification. If not, please explain why. Has 23andMe provided its customers with a guide for how to delete, or request to delete any information currently in 23andMe’s possession? If so, please provide a copy of that guide and specify when it was provided to customers. If not, please explain why, and explain whether 23andMe will contact each of its customers and provide an opportunity to delete their personal information prior to a potential sale of the company or personal information maintained by the company. Please detail the number of requests 23andMe received from its customers to delete their personal information between when 23andMe filed for bankruptcy and the date of the response to this letter. Of those requests, please provide a breakdown of how many requests were made by customers through their 23andMe online accounts and how many were made via customer service calls because customers were unable to successfully delete their information through their online accounts. Of those requests, please detail the number of fulfilled requests. Will 23andMe offer for sale any information in which a customer has requested the deletion of such information? If so, does 23andMe’s privacy policy consider selling information a legitimate purpose for retaining information past a customer's request to delete their information? Will 23andMe deidentify its customers’ personal information prior to selling it or the company? If so, please detail which information will be deidentified. If not, please explain why the company is electing not to deidentify information. CLICK HERE to read the full letter. CLICK HERE to read the story from CNBC. ###